L. Yin

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

W. Choi, J. Winter, M. Piris, 2015, Oncotarget.

Therapeutic effects of chimeric antigen receptor T cells (CAR-T) on relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL): a meta-analysis.

C. Geng, X. Gu, L. Yang, 2020, European review for medical and pharmacological sciences.

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

W. Choi, J. Winter, M. Piris, 2015, Modern Pathology.

Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study

T. Wu, X. He, S. Qi, 2021, ESMO open.

Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.

K. Young, Z. Xu-Monette, Yong Li, 2018, Annals of translational medicine.